BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29664897)

  • 21. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine sensitizes nasopharyngeal carcinoma cells to radiation through inhibition of Sp1 and EMT.
    Wang J; Kang M; Wen Q; Qin YT; Wei ZX; Xiao JJ; Wang RS
    Oncol Rep; 2017 Apr; 37(4):2425-2432. PubMed ID: 28350122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imaging.
    Bao X; Yang Z; Wang S; Zheng Y; Wang M; Gu B; Zhang J; Zhang Y; Zhang Y
    Oncotarget; 2016 Apr; 7(15):20743-52. PubMed ID: 26942701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway.
    Ou J; Pan F; Geng P; Wei X; Xie G; Deng J; Pang X; Liang H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e685-91. PubMed ID: 22208970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy induces cell cycle arrest and cell apoptosis in nasopharyngeal carcinoma via the ATM and Smad pathways.
    Li MY; Liu JQ; Chen DP; Li ZY; Qi B; He L; Yu Y; Yin WJ; Wang MY; Lin L
    Cancer Biol Ther; 2017 Sep; 18(9):681-693. PubMed ID: 28799829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of GnT-V enhances nasopharyngeal carcinoma cell CNE-2 radiosensitivity in vitro and in vivo.
    Zhuo E; He J; Wei T; Zhu W; Meng H; Li Y; Guo L; Zhang J
    Biochem Biophys Res Commun; 2012 Aug; 424(3):554-62. PubMed ID: 22780953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway.
    Chen L; Lin G; Chen K; Wan F; Liang R; Sun Y; Chen X; Zhu X
    Sci Rep; 2020 Oct; 10(1):16328. PubMed ID: 33004943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
    Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
    Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of annexin VII enhances nasopharyngeal carcinoma cell radiosensitivity in vivo and in vitro.
    Gui SJ; Ding RL; Wan YP; Zhou L; Chen XJ; Zeng GQ; He CZ
    Cancer Biomark; 2020; 28(2):129-139. PubMed ID: 31958076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of GnT-V inhibits nasopharyngeal carcinoma cell CNE-2 malignancy in vitro and in vivo.
    Wei T; Li Y; Zhuo E; Zhu W; Meng H; Zhang J
    Cancer Lett; 2011 Oct; 309(2):151-61. PubMed ID: 21676538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Famitinib enhances nasopharyngeal cancer cell radiosensitivity by attenuating radiation-induced phosphorylation of platelet-derived growth factor receptor and c-kit and inhibiting microvessel formation.
    Mu X; Ma J; Zhang Z; Zhou H; Xu S; Qin Y; Huang J; Yang K; Wu G
    Int J Radiat Biol; 2015; 91(9):771-6. PubMed ID: 26073526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells.
    Zhai X; Yang Y; Wan J; Zhu R; Wu Y
    Oncol Rep; 2013 Dec; 30(6):2983-91. PubMed ID: 24064966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
    Feng X; Lv W; Wang S; He Q
    Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
    Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
    Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro study of joint intervention of E-cad and Bmi-1 mediated by transcription activator-like effector nuclease in nasopharyngeal carcinoma].
    Luo T; Yan A; Liu L; Jiang H; Feng C; Liu G; Liu F; Tang D; Zhou T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 43(3):229-239. PubMed ID: 29701183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing nasopharyngeal carcinoma cell radiosensitivity by suppressing AKT/mTOR via CENP-N knockdown.
    Wu LZ; Zou Y; Wang BR; Ni HF; Kong YG; Hua QQ; Chen SM
    J Transl Med; 2023 Nov; 21(1):792. PubMed ID: 37940975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.